# Lead Generation for Medtech and Pharma in Russia and CIS

Medtech and pharma outreach works when the first message addresses a specific need at a clinic, laboratory or distributor: equipment replacement, consumables, service or a new clinical direction. Finding a general procurement address is not enough; you need to identify who creates demand, who checks the economics and who moves a supplier through the purchasing process.

**Figures:** 5.93% — of contacted companies replied across our campaigns; 6,500 — clear positive replies across our campaigns; 97.7% — of addresses accepted the email across our campaigns

## A physician, procurement and finance may all shape the purchase

In a private clinic, the chief physician, department head or laboratory manager often defines the need. They assess clinical fit, staff training and compatibility with the existing installed base. Procurement reviews delivery terms and documentation, while a finance director or owner may join when the decision involves capital equipment, leasing or a long-term contract.

A distributor works differently. Its commercial lead looks at margin, territory and delivery terms; a product manager checks channel demand; procurement evaluates the manufacturer and supply continuity. Medtech and pharma outreach should therefore start with a role map, not a single message offering a generic partnership. For a focused account list, consider [account-based marketing](/en/services/account-based-marketing/).

| Who to contact | What matters to them | A useful first reason to write |
|---|---|---|
| Department head | Clinical use, training, service | Solve a specific procedure need or replace a consumable |
| Procurement | Specification, timing, document package | Check whether an alternative supplier can be considered |
| Distributor commercial lead | Margin, channel, commercial terms | Discuss a product line for an established network |

> Do not mistake a directory job title for the real decision-maker. Procurement may receive the message, but the relevant clinical department may provide the substantive answer.

## Product registration data and procurement plans create a valid reason to reach out

For equipment and consumables, the target list can be built from public medical-device registration data, clinic and diagnostic-centre websites, business listings and sector directories. Published public procurement notices and plans can indicate product categories, regions, institution types and existing equipment. They are not a signal to immediately sell an equivalent product; they are a reason to check whether service, compatible consumables or a backup supply route may be relevant.

For pharmaceutical distribution, useful signals include distributor and pharmacy-network websites, industry event participants and announcements of new branches. Companies should then be deduplicated, grouped by institution type and matched with working contacts in the right function. Our [lead list building](/en/services/lead-list-building/) and [email list verification](/en/services/list-verification/) services cover these steps.

1. Choose one product hypothesis, such as laboratory diagnostic consumables rather than the full catalogue.
2. Select institutions where that hypothesis fits their departments and published product categories.
3. Mark each contact by role: demand owner, procurement, finance or commercial function.
4. Create separate first messages for clinics, laboratories and distributors.

## The offer should reduce implementation risk, not promise a discount

A message saying that you supply medical equipment at competitive prices gives no reason to reply. The recipient already has suppliers, and “competitive” does not explain the risk of switching. A more credible approach is specific and testable: identify a relevant diagnostic direction, offer compatible consumables with technical transition support, and ask who evaluates alternatives in that category.

This does not promise savings before a specification exists. It creates a concrete topic and a low-risk next step: naming the responsible person. For equipment, the first objective may be narrower still: confirm configuration, discuss commissioning or share compatible positions. A meeting request makes sense after the decision-maker has confirmed interest in the category.

A supplier that asks a chief physician for the opportunity to submit its best price is likely to be redirected to procurement. The chain then stops because procurement has no department need, model or reason to compare the offer. Asking whether an expansion is planned and where to send a short specification with service terms produces a reply that can be qualified before sales takes over.

- Useful angles: a specific consumable replacement, service coverage, compatibility, training or backup supply.
- Weak angles: a general catalogue attachment, a “unique offer” or an ungrounded lowest-price promise.
- Premature angle: asking for a demonstration before confirming a need and budget.

## “We buy through tenders” starts qualification; it does not end it

When a clinic says it buys only through a formal procurement process, do not argue or imply that the process can be bypassed. Ask which stage the category is at and where technical materials can be sent for review before requirements are formed. This separates a formal rejection from an opportunity to be considered in a future specification.

A distributor may say it already has a supplier. A useful follow-up is to ask whether the current line covers the required category, geography or service level. If it does not, sales should receive context rather than an abstract lead: product, role, current arrangement and agreed next step. This is the purpose of [reply handling and lead qualification](/en/services/reply-handling/).

- Can the contact assess the product or identify the process owner?
- Has a category, department or product group been named?
- Is it clear what to send next: a specification, compatibility list, service terms or distribution proposal?
- Has the contact agreed to a substantive call or another next step?

## The first campaign result is a demand map, then meetings

Preparation starts with the product line: what can be offered directly to clinics, where a distributor is needed and which technical materials are ready. The list is then built and checked, reply scenarios are agreed and outreach begins in waves. In medtech, pauses in correspondence are normal while a recipient checks with a department, procurement team or existing contract.

Do not judge a campaign only by the number of meetings in its first replies. Early signals include who owns the category, when a contract ends, which positions the current supplier does not cover and who is ready to receive materials. That information improves the next wave and gives sales a prepared reason to continue the conversation. See [how full-service outreach works](/en/services/full-service-outreach/) for the overall launch process.

> Across our campaigns, 48,100 companies replied out of 811,200 companies contacted. This overall figure is not a forecast for a specific manufacturer, clinic or product category.

## When medtech and pharma outreach is not for you

This channel is not ready for a manufacturer whose product cannot yet be described through a specific need, category and institution type. If the plan is to write to every clinic and pharmacy without knowing which department uses the product, who owns the purchase or how the offer differs from the current supplier, outreach will create noise rather than testable demand.

Outreach is also premature when a sale depends on documents or commercial conditions that are not ready: registrations, instructions, certificates, technical specifications, confirmed compatibility, pricing, delivery terms or warranty coverage. If questions about implementation, service and replacement cannot be answered within a few working days, qualified conversations will stall between marketing and sales.

It is not a channel for promising deals this month where approvals are lengthy, an exclusive contract is active, a tender period is closed or nobody can promptly handle replies. It also cannot guarantee a fixed number of opportunities: results depend on the category, region, account list, institution budget and purchasing cycle. If you first need to test segment and offer readiness, start with a [free outreach audit](/en/free-audit/).

## Frequently asked questions

**Can we contact public clinics?**

Yes, you can identify the relevant institution profile and offer technical materials or an alternative supply route. The message must not imply bypassing the procurement procedure. Its purpose is to identify the category owner and understand the stage of demand.

**Who should receive an outreach message about laboratory consumables?**

The laboratory head or relevant clinical-direction lead is often the best first contact because they understand use and compatibility. Procurement should also be mapped for supply terms and formal processing. Both roles belong in the target list.

**Should we attach a catalogue to the first email?**

Usually no. A broad catalogue becomes an attachment the recipient has no reason to review. Name one relevant category and offer to send a specification or compatibility matrix after they reply.

**Can we target distributors instead of clinics?**

Yes, if the manufacturer has clear partnership terms, a product matrix and a defined channel objective. The message should address the distributor’s niche, region or an uncovered category. A generic dealer offer is rarely enough.

**What counts as a useful result before a meeting?**

Useful outcomes include contact details for the category owner, requests for materials, confirmation of demand and information about the current supplier or review timing. These give the sales team facts to continue the conversation. They prevent the next person from having to restart the qualification.

---
Source: https://ot9.ru/en/industries/medtech-and-pharma/ · OT9 (KAP Group) · updated 2026-08-10